Vesalius Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
140 1st St Ste 401, Cambridge, Massachus...Website
www.vesaliustx.comRevenue
<$5 MillionIndustry
About Vesalius Therapeutics
Vesalius Therapeutics is a biotechnology company focused on redefining the treatment of common diseases that account for 90% of human illness, such as heart failure, type II diabetes, and Alzheimer's disease. The company employs a revolutionary platform that utilizes patient-derived experimental models and advanced data science, including AI and machine learning, to identify novel drug targets and develop effective treatments. Their approach emphasizes a patient-centric methodology, challenging traditional assumptions in disease diagnosis and treatment. Vesalius aims to advance innovative therapies by assembling a world-class team of scientists, technologists, and clinicians.Explore more
Vesalius Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Vesalius Therapeutics
Compare insights from companies similar to Vesalius Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Vesalius Therapeutics
<$5M
11-50
Private
-
-
LB
Lisa BrownSenior VP & Head of Business Strategy & Operations
Vesalius Therapeutics Tech Stack
A closer look at the technologies used by Vesalius Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vesalius Therapeutics
Sign Up For FreeTo access detailed company insights
Vesalius Therapeutics is a biotechnology company focused on redefining the treatment of common diseases that account for 90% of human illness, such as heart failure, type II diabetes, and Alzheimer's disease. The company employs a revolutionary platform that utilizes patient-derived experimental models and advanced data science, including AI and ma... Read More
